Active Oxygen and Negative Ion Sanitary Pads for Episiotomy Pain, Healing, and Postpartum Symptoms

May 10, 2026 updated by: KTO Karatay University

Effects of Active Oxygen and Negative Ion Sanitary Pads on Episiotomy Pain, Healing, and Postpartum Physical Symptom Severity in Primiparous Women: A Randomized Controlled Trial

This study is to assess the impact of sanitary pads infused with active oxygen and negative ions on episiotomy pain, wound healing, and postpartum physical symptoms in primiparous women. Participants will be randomly allocated to either the intervention group, utilizing active oxygen and negative ion pads, or the control group, employing normal postpartum pads. The research will assess pain intensity, recovery advancement, and physical manifestations during the initial postpartum phase. The objective is to ascertain if the intervention offers supplementary advantages relative to usual care.

Study Overview

Detailed Description

Episiotomy is a surgical incision made during vaginal birth to enlarge the vaginal opening and support delivery. Although it can help prevent complications during childbirth, many women experience pain, discomfort, difficulty sitting, and delayed wound healing after the procedure. In the postpartum period, appropriate hygiene and wound care are essential to reduce discomfort, prevent infection, and support the healing of the perineal area. The tissues around the vulva and vagina become more sensitive due to increased moisture and hormonal changes, making the choice of hygiene products particularly important.

Sanitary pads containing active oxygen and negative ions have recently been introduced as a new type of hygiene product. These components are believed to improve comfort, support wound healing, and reduce irritation. Although their clinical effects in the postpartum period have not yet been extensively studied, their potential benefits make them a promising option for women recovering from episiotomy.

This study aims to examine whether sanitary pads with active oxygen and negative ions can reduce episiotomy pain, support wound healing, and decrease postpartum physical symptoms in primiparous women. Participants will be randomly assigned to either the intervention group using these special pads or the control group using standard postpartum pads. The findings may contribute to determining whether these products offer additional advantages in the early postpartum recovery process.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Women aged 18 years or older
  • At least primary school education
  • Gestational age between 37 and 42 weeks
  • Single, live, vaginal birth
  • Mediolateral episiotomy performed
  • Hemoglobin level > 11 mg/dL
  • Voluntary participation and ability to provide informed consent

Exclusion Criteria:

  • History of high-risk pregnancy
  • History of high-risk or complicated labor
  • Use of operative vaginal delivery methods (forceps, vacuum, etc.)
  • Presence of additional perineal lacerations, including 3rd-degree tears or anal sphincter injury
  • Cephalopelvic disproportion
  • Postpartum hemorrhage
  • Newborn requiring NICU care
  • Diagnosis of vaginal fungal infection or sexually transmitted infections (e.g., herpes simplex, HPV)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Participants in this group will use standard postpartum sanitary pads during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.
Participants in the control group will use standard postpartum sanitary pads following episiotomy. Routine postpartum care will be provided to all participants. The control product does not contain active oxygen or negative ions.
Experimental: Pad Group
Participants in this group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. All participants will also receive routine postpartum care.
Participants in the intervention group will use sanitary pads containing active oxygen and negative ions during the early postpartum period following episiotomy. The product is applied as a hygiene pad and is not classified as a drug or medical device. Routine postpartum care will be provided to all participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Episiotomy Pain Score
Time Frame: Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum
Episiotomy-related pain will be assessed using a 10-point Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
Measurements will be conducted at: • 24 hours postpartum • 3rd day postpartum • 7th day postpartum
Episiotomy Wound Healing Score
Time Frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

Wound healing will be evaluated using the REEDA Scale (Redness, Edema, Ecchymosis, Discharge, Approximation).

Each item is scored from 0 to 3, with a total score ranging from 0 to 15. Higher scores indicate poorer wound healing (greater tissue trauma).

Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum
Postpartum Physical Symptom Severity
Time Frame: Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

Postpartum physical symptom severity will be measured using the Postpartum Physical Symptom Severity Scale.

The scale consists of 18 items, each rated on a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, 3 = severe), with total scores ranging from 0 to 54.

Higher scores indicate greater severity of postpartum physical symptoms.

Measurement Times: 24 hours after birth 3rd day postpartum 7rd day postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2025

Primary Completion (Actual)

April 1, 2026

Study Completion (Actual)

May 9, 2026

Study Registration Dates

First Submitted

December 3, 2025

First Submitted That Met QC Criteria

March 17, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 10, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared due to ethical restrictions, privacy protection regulations, and institutional policies. Only aggregated study results will be reported

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Episiotomy

Clinical Trials on Active Oxygen and Negative Ion Sanitary Pad

Subscribe